ReviewExperimental hematology & oncology2022

Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting.

Ji-Nuo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.